Physician profile
Catherine B Driver
NPI 1356469266
$16,347.67
in general payments reported to CMS, 2019-2025
42 companies · $3,087 in 2025
The $3,087 reported for 2025 was more than what 78% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,020 · 2020: $566 · 2021: $514 · 2022: $2,772 · 2023: $2,868 · 2024: $3,520 · 2025: $3,087.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,221 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,220.65 |
| Education | $253.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,359.04 | 2019-2025 | Rinvoq, Skyrizi, Humira |
| Amgen INC. | $3,172.37 | 2019-2025 | Enbrel, Otezla, Tavneos |
| Novartis Pharmaceuticals Corporation | $1,627.24 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,101.96 | 2019-2025 | Benlysta |
| Lilly USA, LLC | $996.08 | 2019-2025 | Taltz, Zepbound |
| Janssen Biotech, INC. | $886.53 | 2022-2025 | Tremfya |
| Pfizer INC. | $851.95 | 2019-2025 | |
| Ucb, INC. | $782.86 | 2019-2025 | Cimzia, Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $456.72 | 2019-2025 | Ofev, Cyltezo, Jascayd |
| Astrazeneca Pharmaceuticals LP | $401.41 | 2021-2025 | Saphnelo |
| Radius Health, INC. | $302.80 | 2020-2025 | Tymlos |
| E.R. Squibb & Sons, L.L.C. | $298.77 | 2019-2025 | Orencia |
| Horizon Therapeutics Plc | $231.90 | 2019-2023 | Krystexxa |
| Celgene Corporation | $223.96 | 2019 | |
| Fresenius Kabi USA, LLC | $198.87 | 2023-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $137.17 | 2019-2025 | |
| Aurinia Pharma U.S., INC. | $127.99 | 2022-2025 | Lupkynis |
| Organon LLC | $109.58 | 2024-2025 | Hadlima |
| Medexus Pharma, INC. | $108.23 | 2019 | |
| Alexion Pharmaceuticals, INC. | $95.54 | 2019-2024 | Strensiq |
| Alvogen INC | $83.60 | 2023-2025 | Teriparatide |
| Genentech USA, INC. | $80.85 | 2019-2025 | Gazyva, Actemra |
| Ani Pharmaceuticals, INC. | $70.42 | 2024-2025 | Purified Cortrophin Gel, Sovuna |
| Merck Sharp & Dohme LLC | $68.86 | 2025 | Winrevair |
| Mallinckrodt Hospital Products INC. | $67.04 | 2024-2025 | Acthar |
| Scilex Pharmaceuticals INC. | $64.68 | 2024-2025 | |
| Octapharma USA, INC. | $59.51 | 2024-2025 | Octagam Immune Globulin (Human) |
| Ferring Pharmaceuticals INC. | $53.39 | 2019-2023 | Euflexxa |
| Sandoz INC. | $50.04 | 2024-2025 | Hyrimoz |
| Teva Pharmaceuticals USA, INC. | $47.90 | 2024 | |
| Genzyme Corporation | $36.69 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $26.79 | 2022 | |
| Antares Pharma, INC. | $24.80 | 2019-2020 | |
| Kyowa Kirin, INC. | $23.57 | 2024 | |
| Tonix Medicines, INC. | $19.89 | 2025 | Tonmya |
| Exact Sciences Corporation | $16.85 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $15.76 | 2025 | Ozempic |
| Sanofi-Aventis U.S. LLC | $14.39 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.10 | 2019 | |
| Fidia Pharma USA INC. | $13.44 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $12.33 | 2022 | |
| Gilead Sciences, INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Driver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.